In particular, The Cancer Genome Atlas (TCGA) examined the genomic profile of 200 de novo AML and provided important genomic information of this disease.16 However, the number of CBF-AML in TCGA was limited. The gene discussed is CEBPZ; the disease is acute myeloid leukemia.